ZYLOX-TONBRDG.MED.TECH.H1 Cash Flow Reinvestment Rate
ZYLOX-TONBRDG.MED.TECH.H1 cash flow reinvestment rate. ZYLOX-TONBRDG.MED.TECH.H1 (818) has a Cash Flow Reinvestment Rate of 4.64x as of December 2024, reinvesting €808.05 Million (capex €191.34 Million plus investments €-616.71 Million) from operating cash flow of €174.08 Million. Explore 818 operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of ZYLOX-TONBRDG.MED.TECH.H1 (2023–2024)
Cash flow reinvestment rate of ZYLOX-TONBRDG.MED.TECH.H1 from 2023 to 2024. Historical reinvestment intensity for ZYLOX-TONBRDG.MED.TECH.H1 across 2 annual periods. Explore ZYLOX-TONBRDG.MED.TECH.H1 (818) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
ZYLOX-TONBRDG.MED.TECH.H1 Cash Flow Reinvestment Rate by Year (2023–2024)
ZYLOX-TONBRDG.MED.TECH.H1 cash flow reinvestment rate by year from 2023 to 2024. Year-by-year capital reinvestment analysis for ZYLOX-TONBRDG.MED.TECH.H1. For the full cash flow conversion analysis, see 818 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.64x | €808.05 Million | €174.08 Million | €191.34 Million | ▲ +112.2% |
| 2023 | 2.19x | €215.31 Million | €98.44 Million | €190.92 Million | — |